TY - JOUR AU - Lozier, A. P. AU - Sciacca, R. R. AU - Romagnoli, M. F. AU - Connolly, E. S. PY - 2002 DA - 2002// TI - Ventriculostomy-related infections: a critical review of the literature JO - Neurosurgery VL - 51 UR - https://doi.org/10.1097/00006123-200207000-00024 DO - 10.1097/00006123-200207000-00024 ID - Lozier2002 ER - TY - JOUR AU - Beer, R. AU - Lackner, P. AU - Pfausler, B. AU - Schmutzhard, E. PY - 2008 DA - 2008// TI - Nosocomial ventriculitis and meningitis in neurocritical care patients JO - J Neurol VL - 255 UR - https://doi.org/10.1007/s00415-008-0059-8 DO - 10.1007/s00415-008-0059-8 ID - Beer2008 ER - TY - JOUR AU - Kitchen, W. J. AU - Singh, N. AU - Hulme, S. AU - Galea, J. AU - Patel, H. C. AU - King, A. T. PY - 2011 DA - 2011// TI - External ventricular drain infection: improved technique can reduce infection rates JO - Br J Neurosurg VL - 25 UR - https://doi.org/10.3109/02688697.2011.578770 DO - 10.3109/02688697.2011.578770 ID - Kitchen2011 ER - TY - JOUR AU - Tunkel, A. R. AU - Hartman, B. J. AU - Kaplan, S. L. AU - Kaufman, B. A. AU - Roos, K. L. AU - Scheld, W. M. PY - 2004 DA - 2004// TI - Practice guidelines for the management of bacterial meningitis JO - Clin Infect Dis VL - 39 UR - https://doi.org/10.1086/425368 DO - 10.1086/425368 ID - Tunkel2004 ER - TY - JOUR AU - Paolo, A. AU - Gori, G. AU - Tascini, C. AU - Danesi, R. AU - Tacca, M. PY - 2013 DA - 2013// TI - Clinical pharmacokinetics of antibacterials in cerebrospinal fluid JO - Clin Pharmacokinet VL - 52 UR - https://doi.org/10.1007/s40262-013-0062-9 DO - 10.1007/s40262-013-0062-9 ID - Paolo2013 ER - TY - JOUR AU - Nau, R. AU - Sorgel, F. AU - Eiffert, H. PY - 2010 DA - 2010// TI - Penetration of drugs through the blood–cerebrospinal fluid/blood–brain barrier for treatment of central nervous system infections JO - Clin Microbiol Rev VL - 23 UR - https://doi.org/10.1128/CMR.00007-10 DO - 10.1128/CMR.00007-10 ID - Nau2010 ER - TY - JOUR AU - Drusano, G. L. PY - 2004 DA - 2004// TI - Antimicrobial pharmacodynamics: critical interactions of ‘bug and drug’ JO - Nat Rev Microbiol VL - 2 UR - https://doi.org/10.1038/nrmicro862 DO - 10.1038/nrmicro862 ID - Drusano2004 ER - TY - JOUR AU - Craig, W. A. PY - 1998 DA - 1998// TI - Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men JO - Clin Infect Dis VL - 26 UR - https://doi.org/10.1086/516284 DO - 10.1086/516284 ID - Craig1998 ER - TY - STD TI - European Committee on Antimicrobial Susceptibility Testing (EUCAST). Meropenem: rationale for the EUCAST clinical breakpoints. Version 1.5. 1 June 2009. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Rationale_documents/Meropenem_EUCAST_Rationale_Document_1.5_090601.pdf. Accessed 14 Oct 2016. UR - http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Rationale_documents/Meropenem_EUCAST_Rationale_Document_1.5_090601.pdf ID - ref9 ER - TY - JOUR AU - Dagan, R. AU - Velghe, L. AU - Rodda, J. AU - Klugman, K. PY - 1994 DA - 1994// TI - Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges JO - J Antimicrob Chemother VL - 34 UR - https://doi.org/10.1093/jac/34.1.175 DO - 10.1093/jac/34.1.175 ID - Dagan1994 ER - TY - JOUR AU - Schmutzhard, E. AU - Williams, K. J. AU - Vukmirovits, G. AU - Chmelik, V. AU - Pfausler, B. AU - Featherstone, A. PY - 1995 DA - 1995// TI - Meropenem Meningitis Study Group. A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults JO - J Antimicrob Chemother VL - 36 UR - https://doi.org/10.1093/jac/36.suppl_A.85 DO - 10.1093/jac/36.suppl_A.85 ID - Schmutzhard1995 ER - TY - JOUR AU - Horan, T. C. AU - Andrus, M. AU - Dudeck, M. A. PY - 2008 DA - 2008// TI - CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting JO - Am J Infect Control VL - 36 UR - https://doi.org/10.1016/j.ajic.2008.03.002 DO - 10.1016/j.ajic.2008.03.002 ID - Horan2008 ER - TY - JOUR AU - Roehr, A. C. AU - Frey, O. R. AU - Koeberer, A. AU - Fuchs, T. AU - Roberts, J. A. AU - Brinkmann, A. PY - 2015 DA - 2015// TI - Anti-infective drugs during continuous hemodialysis – using the bench to learn what to do at the bedside JO - Int J Artif Organs VL - 38 UR - https://doi.org/10.5301/ijao.5000377 DO - 10.5301/ijao.5000377 ID - Roehr2015 ER - TY - JOUR AU - Neely, M. AU - Guilder, M. AU - Yamada, W. AU - Schumitzky, A. AU - Jelliffe, R. PY - 2012 DA - 2012// TI - Accurate detection of outliers and subpopulations with Pmetrics, a non-parametric and parametric pharmacometric modeling and simulation package for R JO - Ther Drug Monit VL - 34 UR - https://doi.org/10.1097/FTD.0b013e31825c4ba6 DO - 10.1097/FTD.0b013e31825c4ba6 ID - Neely2012 ER - TY - JOUR AU - Lodise, T. P. AU - Nau, R. AU - Kinzig, M. AU - Drusano, G. L. AU - Jones, R. N. AU - Sorgel, F. PY - 2007 DA - 2007// TI - Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid: results of population pharmacokinetic modelling and Monte Carlo simulation JO - J Antimicrob Chemother VL - 60 UR - https://doi.org/10.1093/jac/dkm325 DO - 10.1093/jac/dkm325 ID - Lodise2007 ER - TY - JOUR AU - Cockcroft, D. W. AU - Gault, M. H. PY - 1976 DA - 1976// TI - Prediction of creatinine clearance from serum creatinine JO - Nephron VL - 16 UR - https://doi.org/10.1159/000180580 DO - 10.1159/000180580 ID - Cockcroft1976 ER - TY - JOUR AU - Roberts, J. A. AU - Paul, S. K. AU - Akova, M. AU - Bassetti, M. AU - Waele, J. J. AU - Dimopoulos, G. PY - 2014 DA - 2014// TI - DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? JO - Clin Infect Dis VL - 58 UR - https://doi.org/10.1093/cid/ciu027 DO - 10.1093/cid/ciu027 ID - Roberts2014 ER - TY - JOUR AU - Nau, R. AU - Lassek, C. AU - Kinzig-Schippers, M. AU - Thiel, A. AU - Prange, H. W. AU - Sorgel, F. PY - 1998 DA - 1998// TI - Disposition and elimination of meropenem in cerebrospinal fluid of hydrocephalic patients with external ventriculostomy JO - Antimicrob Agents Chemother VL - 42 ID - Nau1998 ER - TY - JOUR AU - Lonsdale, D. O. AU - Udy, A. A. AU - Roberts, J. A. AU - Lipman, J. PY - 2013 DA - 2013// TI - Antibacterial therapeutic drug monitoring in cerebrospinal fluid: difficulty in achieving adequate drug concentrations JO - J Neurosurg VL - 118 UR - https://doi.org/10.3171/2012.10.JNS12883 DO - 10.3171/2012.10.JNS12883 ID - Lonsdale2013 ER - TY - JOUR AU - Reiber, H. PY - 2003 DA - 2003// TI - Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics JO - Restor Neurol Neurosci VL - 21 ID - Reiber2003 ER - TY - JOUR AU - Pardridge, W. M. PY - 2012 DA - 2012// TI - Drug transport across the blood–brain barrier JO - J Cereb Blood Flow Metab VL - 32 UR - https://doi.org/10.1038/jcbfm.2012.126 DO - 10.1038/jcbfm.2012.126 ID - Pardridge2012 ER - TY - JOUR AU - Matsuda, T. AU - Ikawa, K. AU - Ikeda, K. AU - Morikawa, N. AU - Tsumura, R. AU - Shibukawa, M. PY - 2009 DA - 2009// TI - LC method for the determination of meropenem in cerebrospinal fluid: application to therapeutic drug monitoring JO - Chromatographia VL - 69 UR - https://doi.org/10.1365/s10337-009-1013-3 DO - 10.1365/s10337-009-1013-3 ID - Matsuda2009 ER - TY - JOUR AU - Chou, Y. W. AU - Yang, Y. H. AU - Chen, J. H. AU - Kuo, C. C. AU - Chen, S. H. PY - 2007 DA - 2007// TI - Quantification of meropenem in plasma and cerebrospinal fluid by micellar electrokinetic capillary chromatography and application in bacterial meningitis patients JO - J Chromatogr B Analyt Technol Biomed Life Sci VL - 856 UR - https://doi.org/10.1016/j.jchromb.2007.06.015 DO - 10.1016/j.jchromb.2007.06.015 ID - Chou2007 ER - TY - JOUR AU - Thalhammer, F. AU - Traunmüller, F. AU - Menyawi, I. AU - Frass, M. AU - Hollenstein, U. M. AU - Locker, G. J. PY - 1999 DA - 1999// TI - Continuous infusion versus intermittent administration of meropenem in critically ill patients JO - J Antimicrob Chemother VL - 43 UR - https://doi.org/10.1093/jac/43.4.523 DO - 10.1093/jac/43.4.523 ID - Thalhammer1999 ER - TY - JOUR AU - Kitzes-Cohen, R. AU - Farin, D. AU - Piva, G. AU - Myttenaere-Bursztein, S. A. PY - 2002 DA - 2002// TI - Pharmacokinetics and pharmacodynamics of meropenem in critically ill patients JO - Int J Antimicrob Agents VL - 19 UR - https://doi.org/10.1016/S0924-8579(01)00474-5 DO - 10.1016/S0924-8579(01)00474-5 ID - Kitzes-Cohen2002 ER - TY - JOUR AU - Novelli, A. AU - Adembri, C. AU - Livi, P. AU - Vallani, S. AU - Mazzei, T. AU - Gaudio, A. R. PY - 2005 DA - 2005// TI - Pharmacokinetic evaluation of meropenem and imipenem in critically ill patients with sepsis JO - Clin Pharmacokinet VL - 44 UR - https://doi.org/10.2165/00003088-200544050-00007 DO - 10.2165/00003088-200544050-00007 ID - Novelli2005 ER - TY - JOUR AU - Roberts, J. A. AU - Kirkpatrick, C. M. AU - Roberts, M. S. AU - Robertson, T. A. AU - Dalley, A. J. AU - Lipman, J. PY - 2009 DA - 2009// TI - Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution JO - J Antimicrob Chemother VL - 64 UR - https://doi.org/10.1093/jac/dkp139 DO - 10.1093/jac/dkp139 ID - Roberts2009 ER - TY - JOUR AU - Krueger, W. A. AU - Bulitta, J. AU - Kinzig-Schippers, M. AU - Landersdorfer, C. AU - Holzgrabe, U. AU - Naber, K. G. PY - 2005 DA - 2005// TI - Evaluation by Monte Carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers JO - Antimicrob Agents Chemother VL - 49 UR - https://doi.org/10.1128/AAC.49.5.1881-1889.2005 DO - 10.1128/AAC.49.5.1881-1889.2005 ID - Krueger2005 ER - TY - JOUR AU - Udy, A. AU - Boots, R. AU - Senthuran, S. AU - Stuart, J. AU - Deans, R. AU - Lassig-Smith, M. PY - 2010 DA - 2010// TI - Augmented creatinine clearance in traumatic brain injury JO - Anesth Analg VL - 111 UR - https://doi.org/10.1213/ANE.0b013e3181f7107d DO - 10.1213/ANE.0b013e3181f7107d ID - Udy2010 ER - TY - JOUR AU - Carlier, M. AU - Carrette, S. AU - Roberts, J. A. AU - Stove, V. AU - Verstraete, A. AU - Hoste, E. PY - 2013 DA - 2013// TI - Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used? JO - Crit Care VL - 17 UR - https://doi.org/10.1186/cc12705 DO - 10.1186/cc12705 ID - Carlier2013 ER - TY - JOUR AU - Huttner, A. AU - Dach, E. AU - Renzoni, A. AU - Huttner, B. D. AU - Affaticati, M. AU - Pagani, L. PY - 2015 DA - 2015// TI - Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study JO - Int J Antimicrob Agents VL - 45 UR - https://doi.org/10.1016/j.ijantimicag.2014.12.017 DO - 10.1016/j.ijantimicag.2014.12.017 ID - Huttner2015 ER - TY - JOUR AU - Udy, A. A. AU - Varghese, J. M. AU - Altukroni, M. AU - Briscoe, S. AU - McWhinney, B. C. AU - Ungerer, J. P. PY - 2012 DA - 2012// TI - Subtherapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations JO - Chest VL - 142 UR - https://doi.org/10.1378/chest.11-1671 DO - 10.1378/chest.11-1671 ID - Udy2012 ER - TY - JOUR AU - Conil, J. M. AU - Georges, B. AU - Mimoz, O. AU - Dieye, E. AU - Ruiz, S. AU - Cougot, P. PY - 2006 DA - 2006// TI - Influence of renal function on trough serum concentrations of piperacillin in intensive care unit patients JO - Intensive Care Med VL - 32 UR - https://doi.org/10.1007/s00134-006-0421-1 DO - 10.1007/s00134-006-0421-1 ID - Conil2006 ER - TY - STD TI - Roehr AC, Frey OR, Köberer A, Fuchs T, Helbig S, Brinkmann A, et al. Creatinine-clearance as predictor for meropenem clearance [abstract EV0080]. Presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases, Copenhagen, Denmark; 2015. ID - ref34 ER -